baber/WOPTO huggingface dataset:
Patent MX-2021001547-A (MX)
Title: Recombinant nucleic acid construct.
Inventor: KEIL OLIVER
IPC: C12N15/09
Filed: 2019-08-07
Abstract: The present invention is related to a recombinant nucleic acid construct comprising in 5'-> 3' direction - a 5' UTR, - a coding region coding for an effector molecule, and - a 3' UTR, wherein the 5' UTR is selected from the group comprising a 5' UTR of a gene or a derivative thereof having a nucleotide identity of at least 85 %, wherein the gene is selected from the group consisting of MCP-1, RPL12s.câ Ang-2, HSP70, H3.3., Galectin-9, GADD34, EDN1, HSP70m5, E-selectin, ICAM-1, IL-6 and vWF.
Patent MX-2021002075-A (MX)
Title: Communication control device, communication control method and communication device.
Inventor: FURUICHI SHO
IPC: H04W16/12
Filed: 2019-08-21
Abstract: This communication control device (40) is provided with an acquisition unit (441) which acquires information about the retention of radio resources by a second wireless system that communicates wirelessly using radio waves in a frequency band used by a first wireless system, and a determination unit which, on the basis of the information about the retention of radio resources, makes a determination about assignment of an interference margin to the second wireless system.
Patent MX-2021004259-A (MX)
Title: Brassica event mon94100 and methods of use thereof.
Inventor: PENG MINGSHENG
IPC: C12N15/09
Filed: 2019-10-14
Abstract: The invention provides recombinant DNA molecules that are unique to Brassica Event MON94100 and transgenic Brassica plants, Brassica plant parts, Brassica seeds, Brassica cells, and agricultural products containing Brassica Event MON94100 as well as methods of using and detecting Brassica Event MON94100. Transgenic Brassica plants containing Brassica Event MON94100 exhibit tolerance to dicamba.
Patent MX-2021005631-A (MX)
Title: Millimeter-wave and ultrasound sensors.
Inventor: SAI BIN
IPC: G01N29/02
Filed: 2021-05-13
Abstract: A fluid mixture parameter determination (FMPD) system for analyzing a fluid mixture while moving includes a computing system and at least one material model that includes two or more model parameters for a plurality of material compositions stored in the memory. An ultrasonic sensor and a millimeter wave (MMW) sensor are each coupled to sense the fluid mixture and are coupled to the computing system. The ultrasonic sensor is for providing ultrasonic data to the computing system including a velocity of the fluid mixture or a volumetric flow, and a velocity of sound (VoS) through the fluid mixture. The MMW sensor is for providing MMW velocity data to the computing system. The computing system is for utilizing the material model together with the ultrasonic data and the MMW velocity data for identifying parameters including a plurality of components in the fluid mixture and a concentration for the plurality of components.
Patent MX-2021005702-A (MX)
Title: Multiplexing highly evolving viral variants with sherlock detection method.
Inventor: MYHRVOLD CAMERON
IPC: C12Q1/6827
Filed: 2019-11-14
Abstract: Methods for generating primers and/or probes for use in analyzing a sample which may comprise a pathogen target sequence are provided, including identifying pan-viral sets of primers and/or probes.
Patent MX-2021006664-A (MX)
Title: Dressing.
Inventor: BOUWENS ELISABETH CORNELIA MARIA
IPC: A23L29/281
Filed: 2019-11-14
Abstract: Food composition in the form of an oil-in-water emulsion, comprising: Â· 65 to 85 wt% of vegetable oil, Â· Water, Â· Hydrolyzed protein selected from the group consisting of pea protein, lentil protein, chick pea protein, lupine protein and mixtures thereof, wherein the composition is free from egg-derived ingredients.
Patent MX-2021007829-A (MX)
Title: Aza-heterobicyclic inhibitors of mat2a and methods of use for treating cancer.
Inventor: KONTEATIS ZENON D
IPC: A61P35/00
Filed: 2019-12-27
Abstract: The present disclosure provides for compounds according to Formula I and their pharmaceutically acceptable salts, tautomers, and/or isotopologues as described in the disclosure. The compounds are inhibitors of methionine adenosyltransferase isoform 2A (MAT2A). Also provided are pharmaceutical compositions and methods of using the compounds for treating cancers, including some cancers in which the gene encoding methylthioadenosine phosphorylase (MTAP) is deleted.
Patent MX-2021015230-A (MX)
Title: Nanoparticle with single site for template polynucleotide attachment.
Inventor: BROWN ANDREW A
IPC: C12Q1/6806
Filed: 2020-12-22
Abstract: Provided is a nanoparticle including a scaffold, a single template site for bonding a template polynucleotide to the scaffold, and a plurality of accessory sites for bonding accessory oligonucleotides to the scaffold, wherein the scaffold is selected from an asymmetrical acrylamide polymer one or a dendrimer including lysyl constitutional repeating units, the single template site for bonding a template polynucleotide to the scaffold is selected from a covalent template bonding site and a noncovalent template bonding site and the plurality of accessory sites for bonding accessory oligonucleotides to the scaffold are selected from covalent accessory oligonucleotide bonding sites and noncovalent accessory oligonucleotide bonding sites. Also provided are methods of using the nanoparticle.
Patent MX-2022002283-A (MX)
Title: Fermentation chamber and method for fermenting coffea fruit.
Inventor: WIRTH ROLAND
IPC: A23F5/02
Filed: 2020-08-21
Abstract: The present invention relates to a fermentation chamber and a method for fermenting coffea fruit. In particular, the present invention relates to a fermentation chamber and a method for the controlled artificial fermentation of whole coffea fruit or coffee beans. In a method according to the invention for fermenting coffea fruit, a respiration of the coffea fruit is measured in a closed chamber containing the fruit to be fermented. A fermentation chamber according to the invention is configured to carry out a method according to the invention for fermenting coffea fruit.
Patent MX-2022002972-A (MX)
Title: Heat exchange system and method of assembly.
Inventor: VODA JOSEPH E
IPC: F28D7/02
Filed: 2020-10-08
Abstract: A method of constructing a coil wound heat exchange module and transporting and installing the coil wound heat exchange module at a plant site, such as an natural gas liquefaction plant. A module frame is constructed and attached to a heat exchanger shell prior to telescoping of a coil wound mandrel into the shell. The module frame includes a lug and two saddles that remain attached to the shell throughout the process and when the heat exchanger is operated. The lug and saddles are constructed and located to stabilize the shell during construction, telescoping and transport (when in a horizontal orientation), and when the shell is installed at the plant site (in a vertical orientation). The lugs and saddles are adapted to allow for thermal expansion and contraction of the shell when it is transitioned from ambient to operating temperature and vice versa.
Patent MX-2022005058-A (MX)
Title: Ready-to-use esthetic compositions.
Inventor: MORGAN PETER
IPC: A61F2/00
Filed: 2020-10-28
Abstract: Described are ready-to-use injectable compositions comprising polymeric microspheres or microparticles of non-animal origin, a hydrogel comprising water and a cellulose-derivative gelling agent, and polysorbate 80. Further described are methods of using the ready-to-use injectable compositions for reparative or plastic surgery, esthetic dermatology, facial contouring, body contouring, and gingival augmentation.
Patent MX-2022007295-A (MX)
Title: Formulation comprising carnauba wax and at least one particular sorbitan monoester.
Inventor: HOEKMAN LEENDERT
IPC: C09D191/06
Filed: 2020-12-18
Abstract: The present invention deals with a formulation comprising at least one ethoxylated C<sub>13</sub>-C<sub>19 </sub>sorbitan monoester, saturated or not; and carnauba wax. Furthermore, the present invention pertains to a coating dilution comprising said formulation and the use of the formulation or of the coating dilution as a cold-end coating on a glass-container.
Patent MX-2022007616-A (MX)
Title: Nonwoven web with increased cd strength.
Inventor: HAYNES BRYAN D
IPC: D04H1/56
Filed: 2019-12-18
Abstract: The present invention discloses a nonwoven web and methods for manufacturing the nonwoven web. One aspect of the invention includes a plurality of outwardly facing nozzles that are positioned at various angles with respect to the axis of a pipe the nozzles are located on. Another aspect of the invention pertains to perturbing at least a portion of a fiber matrix prior to the fiber matrix collecting on a forming surface. The perturbed fiber matrix provides for an increase in cross-machine direction fiber strength of the nonwoven web.
Patent MX-2022009138-A (MX)
Title: Conditionally active anti-her2 antibodies, antibody fragments their immunoconjugates and uses thereof.
Inventor: FREY GERHARD
IPC: C07K16/32
Filed: 2021-01-22
Abstract: A polypeptide having a heavy chain variable region and/or light chain variable region that specifically binds to HER2 protein as well as antibodies and antibody fragments containing the heavy chain variable region and/or the light chain variable region that bind to HER2 protein and multi-specific antibodies that bind to HER2 protein and CD3.. Pharmaceutical compositions and kits comprising the polypeptides, antibodies and antibody fragments and multi-specific antibodies containing the polypeptides are also provided.
Patent MX-2022009425-A (MX)
Title: Optical fiber connector.
Inventor: FORKEY JOSEPH N
IPC: G02B6/42
Filed: 2021-01-29
Abstract: An optical fiber connector is provided. A receptacle has an angled interior surface that acts to guide an optical fiber into the correct position as a jack is inserted into the receptacle.
Patent MX-2022010309-A (MX)
Title: Compositions and methods of using the same for treatment of neurodegenerative and mitochondrial disease.
Inventor: JOHNSTONE SHAWN
IPC: A61P25/28
Filed: 2021-02-22
Abstract: The present disclosure is directed to adenine analogs, methods of making adenine analogs, and methods of treating disorders associated with PINK1 kinase activity including, but not limited to, neurodegenerative diseases, mitochondrial diseases, fibrosis, and/or cardiomyopathy using these analogs. This abstract is intended as a scanning tool for purposes of searching in the particular art and is not intended to be limiting of the present invention.
Patent MX-2022011288-A (MX)
Title: Planar liquid film forming method and planar liquid film forming apparatus.
Inventor: IKUSHIMA KAZUMASA
IPC: B05D1/26
Filed: 2021-03-01
Abstract: [Problem] To provide a technique to form a planar liquid film with less unevenness on a surface than in the prior art, using a jet-type dispensing device. [Solution] Provided is a planar liquid film forming method for forming a planar liquid film on a coating target using a jet-type dispensing device with a plurality of dispensing outlets, each of which is arranged on a rectilinear, nozzle arrangement line 140 and which are spaced by a distance such that liquid materials can merge to form a linear liquid film when the liquid materials touch the coating target, the method comprising a linear unit liquid film forming step of dispensing the liquid materials such that a plurality of liquid lumps ejected simultaneously from the plurality of dispensing outlets do not contact each other before touching the coating target and the liquid materials merge when the liquid materials touch the coating target, thereby forming a linear unit liquid film 404, and a specific planar liquid film forming step of continuously repeating the linear unit liquid film forming step while moving the jet-type dispensing device and the coating target relative to each other in a direction perpendicular to the nozzle arrangement line 140, so as to let a plurality of linear unit liquid films 404 merge and form a specific planar liquid film 405. Also provided is an apparatus for conducting the method.
Patent MX-2022014095-A (MX)
Title: Novel tebipenem pivoxil immediate and modified release oral dosage forms.
Inventor: LI SHOUFENG
IPC: A61K31/427
Filed: 2019-06-14
Abstract: Immediate and modified release oral dosage forms of tebipenem pivoxil including dosage form cores are provided. The dosage form core includes tebipenem pivoxil in free base or salt form, and excipients including a binder, a lubricant, optionally a diluent, and optional additional excipients. The weight to weight ratio of tebipenem pivoxil to the excipients in the dosage form core is from 30:60 to 60:30. The disclosure includes methods of treating bacterial infections including complicated urinary tract infections.
Patent MX-2022014522-A (MX)
Title: Laser welding method.
Inventor: BRESCOE RYAN
IPC: B23K26/06
Filed: 2021-05-06
Abstract: A method for laser keyhole welding is disclosed to weld two pieces together made of a metal alloy. The method independently adjusts power in a focused center beam and power in a concentric focused annular beam. At the termination of a weld, the power of the annular beam (PA) is reduced, motion of the focused beams is stopped, the power of the center beam (Pc) is increased, and the power of both beams is initially ramped down rapidly and then ramped down slowly. Increasing the power of the center beam equalizes the temperature of both pieces prior to solidification and cooling at the termination of the weld. An additional pulse of power may be applied to prevent the formation of defects or to erase any defects.A method for laser keyhole welding is disclosed to weld two pieces together made of a metal alloy. The method independently adjusts power in a focused center beam and power in a concentric focused annular beam. At the termination of a weld, the power of the annular beam (PA) is reduced, motion of the focused beams is stopped, the power of the center beam (Pc) is increased, and the power of both beams is initially ramped down rapidly and then ramped down slowly. Increasing the power of the center beam equalizes the temperature of both pieces prior to solidification and cooling at the termination of the weld. An additional pulse of power may be applied to prevent the formation of defects or to erase any defects. A pharmaceutical composition, suitably in the form of a tablet, is described comprising intragranular and extragranular components. The intragranular components comprise a pharmaceutically effective amount of paracetamol, calcium carbonate provided in the form of particles having a d50 greater than 11Î¼m, and at least one binding agent and the extragranular components comprise a pharmaceutically effective amount of aspirin, and at least one hydrophilic colloid. Optionally the compositions comprise caffeine.
Patent MX-2022016358-A (MX)
Title: Steel sheet, member, method for producing said steel sheet, and method for producing said member.
Inventor: NAKAGAITO TATSUYA
IPC: C22C38/00
Filed: 2021-06-30
Abstract: The purpose of the present invention is to provide: a steel sheet which has a tensile strength (TS) of 590 MPa or more as well as excellent collision characteristics; a member; a method for producing this steel sheet; and a method for producing this member.ã¿¿A steel sheet according to the present invention has a component composition wherein the carbon equivalent Ceq is not less than 0.35% but less than 0.60%, while having a steel structure that contains, in area ratios, from 40% to 85% of ferrite, from 10% to 55% of tempered martensite and bainite in total, and from 3% to 15% of residual austenite, with the total of ferrite, tempered martensite, bainite and residual austenite being 93% or more. If this steel sheet is subjected to 90Â° bending in the rolling (L) direction about the axis in the width (C) direction at a (curvature radius)/(sheet thickness) ratio of 4.2, the amount of change in the value of (grain size in sheet thickness direction)/(grain size in direction perpendicular to sheet thickness) of the tempered martensite before and after the bending is 0.50 or more in an L cross-section within the region of 0 to 50 Î¼m from the compression-side steel sheet surface; and the tensile strength is 590 MPa or more.
Patent MX-JL01000023-A (MX)
Title: Tequilana weber blue agave plants regeneration by means of somatic embriogenesis.
Inventor: BENJAMIN RODRIGUEZ GARAY
IPC: C12N15/00
Filed: 2001-11-08
Abstract: The present invention discloses a unicellular regeneration process of plants of the specie (tequilana weber blue agave) by means of the in vitro culture technique of somatic indirect embryogenesis. It is about of plants generated from one single cell coming from the dedifferentiated tissues (callus); the process comprises the following steps: utilization of somatic cells which are taken to a culture mean that is prepared using the basic salts of the mean MS (Murashige and Soog, 1962), the vitamins L2 (Philips and Collins, 1979), gelled with agar and it is employed as a carbon source sucrose, and also supplemented with auxin 2, 4- dichlorophenoxyacetic acid and cytocinine benzyl-adenine, the exposure time to the induction mean is of about 15 and 80 days. Once the induction period is over, the embryogenic calluses are transferred to a solid culture mean for the expression and germination. The vegetal material is incubated under the following conditions: temperature of 27 +/- °C, a lumin ous intensity of 1500 lights and a photoperiod of 16 hours. This methodology is a tool which can be used to perform micro-propagation as well as the genetic enhancement in vitro of the specie.
Patent MX-PA00009376-A (MX)
Title: Azt derivatives exhibiting spermicidal and anti-viral activity.
Inventor: D CRUZ OSMOND
IPC: A61K31/7042
Filed: 1999-03-23
Abstract: Contraceptive activity as well as anti-viral protection can be provided by contraceptive compositions containing a pyrimidine-based nucleoside or nucleotide exhibiting spermicidal or sperm-immobilizing activity. In one example, the active ingredient contains a thymine ring (e.g. AZT) that has 5-halo, 6-alkoxy substitution. Additional improvements in anti-HIV activity for certain AZT derivatives are seen by providing the pentose ring of AZT with aryl phosphate substitution.
Patent MX-PA01004953-A (MX)
Title: Apparatus with improved safety features for high temperature industrial processes.
Inventor: DAVID MARK BERGERON
IPC: B01J19/24
Filed: 2001-05-17
Abstract: A conical reactor head for use in chemical processes or other systems is provided. The reactor head includes a robust internal insulator to boost efficiency while maintaining safety by allowing the reactor head to self-radiate at high temperatures. The reactor head also includes a plurality of support lugs to protect its bottom flange from scratches or other damage when the reactor head is set on the ground. The reactor head is adapted to connect to a catalyst-containing barrel which is specially designed to facilitate easy installation and removal of catalysts or other equipment from outside the barrel. The reactor may be coupled with a rotation vane to induce laminar flow at the inlet of the reactor to increase reactor efficiency and prolong catalys.
Patent MX-PA01009446-A (MX)
Title: Increased hydrophobic stability of a softening compound.
Inventor: DALE A BURGHARDT
IPC: D21H17/13
Filed: 2001-09-19
Abstract: A tissue product applied with a softening treatment is provided. The softening treatment contains a softening compound, such as a amino-functional polysiloxane, and a polymerization inhibitor. The polymerization inhibitor inhibits cross-linking of the softening compound when subjected to non-ideal conditions, e.g., stored for 8 weeks at 100 F. and 80% relative humidity. In some embodiments, for example, the polymerization inhibitor can be an alkyl siloxane, such as hexamethyl disiloxane.
Patent MX-PA01011396-A (MX)
Title: Modifiers for anionic polymerization.
Inventor: MICHAEL GRUN
IPC: C08F36/00
Filed: 2001-11-08
Abstract: The invention provides modifiers for the anionic polymerization of conjugated dienes or of conjugated dienes with vinylaromatic compounds, wherein the modifiers are specific aminoethers.
Patent MX-PA02001082-A (MX)
Title: Process for making ammonium glyphosate flakes.
Inventor: KRAMER RICHARD M
IPC: A01N57/20
Filed: 2000-07-26
Abstract: A process is provided for preparing ammonium glyphosate flakes, comprising (a) mixing (i) solid particulate glyphosate acid, (ii) water in an amount of about 0.5 to about 3 parts by weight per part by weight of glyphosate acid, and (iii) a base that supplies ammonium cations, in an amount of about 0.8 to about 1.25 mole equivalents of ammonia per mole of glyphosate acid, to form an aqueous reaction medium; (b) allowing the glyphosate acid to react with the base in the reaction medium to form a reaction product comprising a concentrated aqueous solution of ammonium glyphosate; (c) drying the reaction product by contact thereof with a heated surface to form, primarily by evaporation of water, a solid deposit on the heated surface; and (d) scraping the solid deposit off the heated surface to recover dry flakes of ammonium glyphosate.
Patent MX-PA02002094-A (MX)
Title: Shaft bearing.
Inventor: FRANK SCHMIDT
IPC: F16C27/06
Filed: 2002-02-27
Abstract: A shaft bearing, which includes a roller bearing (1) having an outer ring (2) enclosed at its outer circumference by a supporting ring (3) at a radial distance, at least one first spring element (5), which is elastically yielding in the axial direction and the radial direction, being positioned in the gap (4) formed by the radial distance. Outer ring (2) is relatively non-rotatably connected to a vibration absorber (6).
Patent MX-PA02002151-A (MX)
Title: Feature modeling in a finite element model.
Inventor: STEVEN B WARD
IPC: G06T17/05
Filed: 2001-06-29
Abstract: A method for simulating a physical system using finite element techniques, wherein two or more distinct models corresponding to distinct regions within the modeled system are solved, each with a corresponding evaluator. Nodes which lie on the boundaries between the models may have different values corresponding to the different models. When a particular model is solved, the evaluator for that model is used to obtain the appropriate values for each of these common nodes. In one embodiment, a first model is defined, then a region corresponding to a particular feature within the system is carved out of it. A finite element model corresponding to the feature is then inserted into the region. The finite elements may be adapted to share nodes on the boundaries between them.
Patent MX-PA02004725-A (MX)
Title: Cooling of electrical machines.
Inventor: STEVEN PAUL RANDALL
IPC: H02K9/22
Filed: 2002-05-10
Abstract: A cooling system for an electrical machine comprises at least one set of heat conducting inserts positioned so as to transmit heat from at least one part of the winding in the stator to a heatsink. The heatsink may be the frame of the machine itself, but could also be a coolant pipe mounted at one or both ends of the stator. One form of insert is arranged between windings to draw heat away from the sides of the poles. Another form of insert is arranged on the ends of the poles to draw heat from that region.
Patent MX-PA02005080-A (MX)
Title: Anti-inflammatory oxo derivatives and hydroxy derivatives of pyrrolizines, and their pharmaceutical use.
Inventor: LAUFER STEFAN
IPC: A61P29/00
Filed: 1999-11-23
Abstract: The invention relates to compounds of formula (I), wherein one of the radicals R8 and R9 represents a hydrogen atom or an alkyl group and the other represents hydroxyl, alkoxy or acyloxy or whereby, R8 and R9, together with the carbon atom, on which they are bound, represent a carbonyl group, and the radicals R1 to R7 have the meanings as cited in the description. The compounds inhibit the release of different mediators of the arachidonic acid cascade and are thus useful for preventing allergically induced illnesses or for treating illnesses of the rheumatic form circle.